nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination
|
Vergati, Matteo |
|
2010 |
60 |
2 |
p. 197-206 |
artikel |
2 |
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings
|
Oudard, Stéphane |
|
2010 |
60 |
2 |
p. 261-271 |
artikel |
3 |
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings
|
Oudard, Stéphane |
|
|
60 |
2 |
p. 261-271 |
artikel |
4 |
CD8 Co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression
|
Zloza, Andrew |
|
2010 |
60 |
2 |
p. 291-297 |
artikel |
5 |
CDR2 antigen and Yo antibodies
|
Totland, Cecilie |
|
2010 |
60 |
2 |
p. 283-289 |
artikel |
6 |
Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery
|
Driessens, Gregory |
|
2010 |
60 |
2 |
p. 273-281 |
artikel |
7 |
Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model
|
Maes, Wim |
|
2010 |
60 |
2 |
p. 153-160 |
artikel |
8 |
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors
|
Andersen, Rikke Sick |
|
2010 |
60 |
2 |
p. 227-234 |
artikel |
9 |
IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype
|
Albrecht, Jana |
|
2010 |
60 |
2 |
p. 235-248 |
artikel |
10 |
Migration and immunological reaction after the administration of αGalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer
|
Kurosaki, Motoyoshi |
|
2010 |
60 |
2 |
p. 207-215 |
artikel |
11 |
Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis
|
Warrington, Richard J. |
|
2010 |
60 |
2 |
p. 187-195 |
artikel |
12 |
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909
|
Kuball, Jürgen |
|
2010 |
60 |
2 |
p. 161-171 |
artikel |
13 |
Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy
|
Wölfl, Matthias |
|
2010 |
60 |
2 |
p. 173-186 |
artikel |
14 |
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
|
González-Reyes, Salomé |
|
2010 |
60 |
2 |
p. 217-226 |
artikel |
15 |
“Tumor immunology meets oncology (TIMO) VI” from 7th to 8th of May 2010 in Halle, Germany
|
Quandt, Dagmar |
|
2010 |
60 |
2 |
p. 299-303 |
artikel |
16 |
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
|
Lesterhuis, W. Joost |
|
2010 |
60 |
2 |
p. 249-260 |
artikel |